MX366887B - Tetrahidrato de la sal de l-arginina del ácido s-(-)-9-fluoro-6,7-dihidro-8- (4-hidroxipiperidin-1-il) -5-metil-1-oxo-1h, 5h-benzo[i,j] quinolizin-2-carboxílico puro, y un proceso para su preparación. - Google Patents

Tetrahidrato de la sal de l-arginina del ácido s-(-)-9-fluoro-6,7-dihidro-8- (4-hidroxipiperidin-1-il) -5-metil-1-oxo-1h, 5h-benzo[i,j] quinolizin-2-carboxílico puro, y un proceso para su preparación.

Info

Publication number
MX366887B
MX366887B MX2014003770A MX2014003770A MX366887B MX 366887 B MX366887 B MX 366887B MX 2014003770 A MX2014003770 A MX 2014003770A MX 2014003770 A MX2014003770 A MX 2014003770A MX 366887 B MX366887 B MX 366887B
Authority
MX
Mexico
Prior art keywords
hydroxypiperidin
quinolizine
benzo
dihydro
oxo
Prior art date
Application number
MX2014003770A
Other languages
English (en)
Other versions
MX2014003770A (es
Inventor
Kumar Gangakhedkar Kiran
Varangaonkar Aniruddha
Mohammed Diwan Furqan
Datatraya Yeole Ravindra
Deo Keshav
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Publication of MX2014003770A publication Critical patent/MX2014003770A/es
Publication of MX366887B publication Critical patent/MX366887B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se describe tetrahidrato de la sal de L-arginina del ácido S-(-)-9-fluoro-6,7-dihidro-8-(4-hidroxipiperidin-1-il) 5-metil-1-oxo-1H,5H-benzo[i,j] quinolizin-2-carboxílico puro y un proceso para su preparación.
MX2014003770A 2011-09-28 2012-01-06 Tetrahidrato de la sal de l-arginina del ácido s-(-)-9-fluoro-6,7-dihidro-8- (4-hidroxipiperidin-1-il) -5-metil-1-oxo-1h, 5h-benzo[i,j] quinolizin-2-carboxílico puro, y un proceso para su preparación. MX366887B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2740MU2011 2011-09-28
PCT/IB2012/050074 WO2013046061A1 (en) 2011-09-28 2012-01-06 Pures-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1h,-5h-benzo[i,j]quinolizine-2- carboxylic acid l-arginine salt tetrahydrate and a process for its preparation

Publications (2)

Publication Number Publication Date
MX2014003770A MX2014003770A (es) 2014-04-30
MX366887B true MX366887B (es) 2019-07-29

Family

ID=45498072

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014003770A MX366887B (es) 2011-09-28 2012-01-06 Tetrahidrato de la sal de l-arginina del ácido s-(-)-9-fluoro-6,7-dihidro-8- (4-hidroxipiperidin-1-il) -5-metil-1-oxo-1h, 5h-benzo[i,j] quinolizin-2-carboxílico puro, y un proceso para su preparación.

Country Status (12)

Country Link
US (1) US20140296280A1 (es)
EP (1) EP2776433A1 (es)
JP (1) JP6126102B2 (es)
KR (1) KR20140054307A (es)
CN (1) CN103842361A (es)
AU (1) AU2012313987B2 (es)
BR (1) BR112014006401A2 (es)
CA (1) CA2850159A1 (es)
MX (1) MX366887B (es)
RU (1) RU2594166C2 (es)
WO (1) WO2013046061A1 (es)
ZA (1) ZA201401262B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX382717B (es) * 2017-04-14 2025-03-13 Wockhardt Ltd Composiciones antibacterianas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7247642B2 (en) * 1999-05-07 2007-07-24 Wockhardt Limited Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment
ATE378335T1 (de) * 2000-05-08 2007-11-15 Wockhardt Ltd Chirale fluorochinolizinon arginine salze
US6664267B1 (en) * 2002-05-28 2003-12-16 Wockhardt Limited Crystalline fluoroquinolone arginine salt form
EP1660495B1 (en) * 2003-09-04 2007-07-11 Wockhardt Limited Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate
JP5384119B2 (ja) * 2006-03-07 2014-01-08 ウォックハート リミテッド ベンゾキノリジン−２−カルボン酸のプロドラッグ

Also Published As

Publication number Publication date
EP2776433A1 (en) 2014-09-17
CA2850159A1 (en) 2013-04-04
JP6126102B2 (ja) 2017-05-10
NZ621358A (en) 2016-03-31
JP2014527998A (ja) 2014-10-23
RU2594166C2 (ru) 2016-08-10
KR20140054307A (ko) 2014-05-08
RU2014115989A (ru) 2015-11-10
WO2013046061A1 (en) 2013-04-04
CN103842361A (zh) 2014-06-04
BR112014006401A2 (pt) 2017-03-28
US20140296280A1 (en) 2014-10-02
MX2014003770A (es) 2014-04-30
AU2012313987B2 (en) 2016-11-24
AU2012313987A1 (en) 2014-03-06
ZA201401262B (en) 2015-10-28

Similar Documents

Publication Publication Date Title
MY182428A (en) Crystalline forms of a prolyl hydroxylase inhibitor
PH12013500554A1 (en) Process for preparing pan-cdk inhibitors of the formula (i) and intermediates in the preparation
MX2013000009A (es) Procedimiento de preparacion de la sal de l-arginina de perindoprilo.
HK1205095A1 (en) Methods and intermediates for preparing pharmaceutical agents
GB201107985D0 (en) Process
JO2930B1 (en) A new process for the synthesis of ivabradine and salts of addition with a pharmaceutically acceptable acid
MX2011012233A (es) Soluciones de retinoide topicas.
EP2663546A1 (fr) Procede de production de composes nitrile-acide gras
JO2854B1 (en) A new method for the synthesis of anfabradine and its added salts with acid is pharmaceutically acceptable.
EP2692721A4 (en) DIAMOND COMPOUND WITH A SULFURIC ACID GROUP AND METHOD OF MANUFACTURING THEREOF
MY170662A (en) New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid
MX2014003770A (es) Tetrahidrato de la sal de l-arginina del acido s-(-)-9-fluoro-6,7-dihidro-8-(4-hidroxipiperidin-1-il)-5-metil-1- oxo-1h,5h-benzo[i,j] quinolizin-2-carboxilico puro, y un proceso para su preparacion.
PH12015500527A1 (en) Macrolide derivatives, preparation and therapeutic use thereof
EP2681185B8 (de) Verfahren zur herstellung von aryl- und heteroarylessigsäure-derivaten
IN2014DE01203A (es)
MX2013002990A (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable.
JO3083B1 (ar) عملية جديدة لتخليق إيفابرادين وأملاحه المضافة مع حمض مقبول صيدلانيا
EP2750706A4 (en) 2-HYDROXYHIPPURIC ACID ANALOGUES AND METHODS FOR THEIR SYNTHESIS AND USE
MX363563B (es) Proceso para la preparación de un tioprecursor de estatinas.
PL394460A1 (pl) Sposób plazmowej modyfikacji kwasu α-ketoglutarowego i soli kwasu α-ketoglutarowego
PL396871A1 (pl) Kwas naftaleno-1,4-difosfonowy, sposób wytwarzania kwasu naftaleno-1,4-difosfonowego i zastosowanie kwasu naftaleno-1,4-difosfonowego
TN2013000128A1 (en) Process for preparing pan-cdk inhibitors of the formula (1), and intermediates in the preparation
AU2011900159A0 (en) Process for capturing acid gases
MX345518B (es) Compuestos analgesicos, metodos, y formulaciones.
UA67859U (en) 3,4-dimethyl-1-ethylcyclohex-3-ene carboxylic acid

Legal Events

Date Code Title Description
FG Grant or registration